Patent ID: 11883383
Assignee: VTV THERAPEUTICS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 1:
2. A crystalline form of a gentisate salt of [3-(4-{2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl}phenoxy)-propyl]-diethylamine, wherein the crystalline form is:
a) characterized by at least two of the following features (I-i)-(I-iv):
(I-i) an X-ray Powder Diffraction (XRPD) pattern having peaks at 2θ angles of 7.5°, 21.2°, and 24.7°±0.2°;
(I-ii) a Differential Scanning calorimetry (DSC) profile as shown in FIG. 37;
(I-iii) a Thermogravimetry Analysis (TGA) profile as shown in FIG. 37; or
(I-iv) a 13C Solid-state Nuclear Magnetic Resonance (SSNMR) spectrum as shown in FIG. 65; or

b) characterized by at least two of the following features (I-i)-(I-iii):
(I-i) an XRPD pattern having peaks at 2θ angles of 13.3°, 18.4°, and 21.2°±0.2°;
(I-ii) a DSC profile as shown in FIG. 40; or
(I-iii) a TGA profile as shown in FIG. 40.